Metagenomics Market
Increase in Diabetic Patients to Surge the Demand for Metagenomics: FMI Analyzes data from 30+ Countries
Metagenomics Market by Product Type, Application, End User & Region | Forecast 2023 to 2033
Metagenomics Market Snapshot (2023 to 2033)
As per the recent market research conducted by FMI, the global metagenomics market is expected to advance at a CAGR of 6.9% during the forecast period. The valuation in 2023 is expected to be US$ 202.9 million. By 2033, the market value is expected to be US$ 394.2 million.
Key factors that may propel the market growth are:
- The rising use of metagenomics techniques across varied areas increased government and private sector investment in large-scale sequencing projects.
- An increase in chronic illness cases, and breakthroughs in sequencing technology.
- Rapid advances in sequencing methods have enabled humans to get a better grasp of previously undiscovered molecular genetics.
- Metagenomics is gaining popularity for large-scale genomics applications aimed at determining the taxonomic and functional makeup of microbial communities.
- The growing use of metagenomics in clinical diagnostics is propelling the metagenomics industry forward.
The COVID-19 pandemic is likely to redirect attention to the growing metagenomics business.
As per an article in Future Science, 2021, pandemic risk calculations use metagenomics to trace the molecular changes in pathogens during their emergence. This could aid in the prediction of hotspots of emergence, populations at risk, and pathogens undergoing genetic evolution. Given the foregoing, the COVID-19 pandemic is projected to have a substantial influence on the metagenomics analysis.
Collaborations between government and business entities are also expected to generate sales opportunities for metagenomics throughout the projected period. For example, in October 2021, the USA Food and Drug Administration, the National Institute of Health, and 15 commercial groups entered a strategic partnership. The idea was to discover gene therapy for 30 million Americans who suffer from uncommon diseases.
Key developments in the market include the advancement of sequencing technologies from shotgun sequencing to high-throughput, next-generation sequencing, and third-generation sequencing. These developments would provide an impetus for favorable growth opportunities for market players in the coming years.
As per the regional analysis, North America is expected to be the dominant market. The market will be driven by increased demand for metagenomic sequencing due to the existence of biotechnological firms, and the rising incidence of chronic illnesses. An increase in the number of human genome research initiatives and the adoption of improved diagnostic procedures are also expected to drive market growth.
Attributes |
Value |
Metagenomics Market Value (2022) |
US$ 189.2 million |
Metagenomics Market Expected Value (2023) |
US$ 202.9 million |
Metagenomics Market Forecast Value (2033) |
US$ 394.2 million |
Metagenomics Market Expected CAGR (2023 to 2033) |
6.9% |
Let us know your requirement to get
100% FREE customization
Historical CAGR (2017 to 2022) vs Anticipated CAGR Trend Analysis
Metagenomics has been in demand owing to its ability to study every type of microorganism, regardless of whether it can be cultured or not. The ability to study prokaryotes and viruses in the environment through the analysis of their DNA makes metagenomics a powerful method. The capability to identify crucial bioactive compounds, enzymes, and antibiotics make metagenomics a highly reliable method. Owing to its increased usage the anticipated CAGR is expected to be more than the historical CAGR. The historical CAGR for the market was 6.4% and the anticipated CAGR is 6.9%.
- Short-term (2023 to 2026): Increasing the prevalence of various chronic and infectious diseases such as cancer might surge the adoption of metagenomics for the timely diagnosis of these diseases. The growing adoption of metagenomics in clinical diagnostics is providing an impetus for market growth. Metagenomics assists in disease detection in crops and livestock by exploring the interaction between plants and microbes, which might drive the growth in this niche.
- Medium-term (2026 to 2029): Rising adoption of metagenomics across diverse fields, and increasing investments by government and private agencies for large-scale sequencing projects might happen during this period. Rapid advancements in sequencing tools have allowed for a greater understanding of molecular genetics which was previously unknown to humans. Metagenomics might also gain immense traction for large-scale genomics applications to study the taxonomic and functional composition of microbial communities.
- Long-term (2029 to 2033): Growing demand for fuels and biofuels across the world is anticipated to further accelerate the market growth over the assessment period. Metagenomics might become one of the promising research tools for discovering novel enzymes to produce biofuel in an efficient way across industries.
How is Increasing Adoption of Metagenomics in Chronic Disease Diagnosis boosting Sales?
As the global burden of chronic diseases continues to rise, research is conducted to test the potentiality of metagenomics for timely diagnosis. This is anticipated to bolster the growth in the metagenomics market.
Metagenomic diagnostics help predict and manage the treatment of a plethora of diseases. It can be effectively used to discover hidden genetic features that could prove vital in various usages. Key applications are in novel enzymes, bioactive molecules, and genes with better or new biochemical functionalities.
In addition, the growing adoption of diagnostic tests based on metagenomics for the early diagnosis of genetic disorders will further expand the market.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWill Growing Efforts for controlling Environmental Toxicology influence Demand?
Metagenomics plays a crucial role in bioremediation, a process that uses naturally occurring or artificially introduced microorganisms to break down environmental pollutants.
Metagenomic approaches reveal useful information about the metagenome of microorganisms, which play a key role in the biogeochemical cycles. These are also used for the detoxification of environmental pollutants using culture-independent molecular techniques.
Targeted metagenomics is used to study the phylogenetic diversity and relative abundance of a particular gene in the environment. The increasing need for preventing and controlling environmental toxicity through bioremediation will therefore create growth opportunities for the market.
Comparative View for Metagenomics Market
Metagenomics Market:
Attributes |
Metagenomics Market |
Anticipated CAGR (2023 to 2033) |
6.9% |
Market Value (2023) |
US$ 202.9 million |
Growth Factor |
The surge in chronic illness |
Future Opportunities |
Increased government and private sector investment |
Market Trends |
Advancements in sequencing tools |
Health and Medical Microalgae Market:
Attributes |
Health and Medical Microalgae Market |
Anticipated CAGR (2023 to 2033) |
6% |
Market Value (2023) |
US$ 725 million |
Growth Factor |
Surging demand for natural ingredients in healthcare |
Future Opportunities |
Increase in consumption of clean-label products |
Market Trends |
Manufacturers focus on consumers who suffer from lifestyle diseases |
Algae Omega Market:
Attributes |
Algae Omega Market |
Anticipated CAGR (2023 to 2033) |
4% |
Market Value (2023) |
US$ 1,063.4 million |
Growth Factor |
Massive demand for clinical nutrition |
Future Opportunities |
Burgeoning demand for animal feeds |
Market Trends |
Manufacturers lay special emphasis on millennials |

A unified Market Research Subscription Platform, built for today's disparate research needs.
Country-wise Insights
Regions | North America |
Countries | United States of America |
CAGR (2023 to 2033) | 8% |
Regions | Europe |
Countries | United Kingdom |
CAGR (2023 to 2033) | 5.8% |
Regions | Asia Pacific |
Countries | China, Japan, India |
CAGR (2023 to 2033) | 8.6%, 5.3%, 6.8% |
Will the USA market continue witnessing high demand?
Rising prevalence of chronic diseases fueling the adoption of metagenomic sequencing
The USA is projected to dominate the North American market over the forecast period. Increasing demand for metagenomic sequencing due to the heavy presence of biotechnological companies and the rising prevalence of chronic diseases are expected to drive the market. A surge in the number of human genome research projects and the adoption of better diagnostic techniques might as well propel growth.
Attributes |
Details |
United States of America Market Expected Size (2033) |
US$ 110.3 million |
United States of America Market Absolute Dollar Growth |
US$ 59.4 million |
CAGR % 2017 to 2022 |
6.2% |
The USA is home to some of the leading pharmaceutical and biotech companies in the world. These companies are constantly employing techniques such as metagenomic sequencing for studying the nature and pattern of diseases as well as for developing targeted medicines.
What is the United Kingdom market outlook?
The heavy presence of end-use industries generates demand for metagenomic approaches like shotgun sequencing in the United Kingdom
The United Kingdom market is slated to grow at a robust pace over the forecast period, owing to the presence of leading end-use industries, and the growing popularity of shotgun sequencing. The high prevalence of genetic disorders and the continuous rise in genetic research projects are also expected to surge the growth.
Attributes |
Details |
United Kingdom Market Expected Size (2033) |
US$ 11.1 million |
United Kingdom Market Absolute Dollar Growth |
US$ 4.8 million |
CAGR % 2017 to 2022 |
8.8% |
Increasing efforts by the government and private organizations to make the United Kingdom an advanced genomic healthcare system market. The country is one of the leading players in genetics and genome sequencing and spends billions of dollars on developing new diagnostic tools and drugs for a wide range of diseases.
What is driving the China market?
Increasing investments in gene research triggering growth in China
As per FMI, China is anticipated to lead the metagenomics market across the Asia Pacific excluding the Japan region throughout the forecast period. Growth in the market is driven by increasing demand for genetic sequencing, the prevalence of infectious diseases, and increasing investments in gene research.
Attributes |
Details |
China Market Expected Size (2033) |
US$ 40.2 million |
China Market Absolute Dollar Growth |
US$ 22.5 million |
CAGR % 2017 to 2022 |
7.3% |
Rising investments in the healthcare sector by the government and other organizations are expected to fuel the growth in the market. For instance, in 2017 China launched the world’s largest human genome research project of 100,000 people to document their genetic makeup.
The growing popularity of metagenomics-based advanced gene sequencing techniques across agricultural and pharmaceutical industries is positively impacting growth.
Japan market: Driven by wildlife conservation
The Japanese market is mainly driven by a number of endangered species, some of which are the Asian leopard cat, Blakiston’s fish-owl, brown spotted catshark, etc. The zoologists and wildlife veterinarians in Japan are laying a lot of emphasis on their protection.
Metagenomics plays a key role in their conservation. The DNA sequencing technology of metagenomics allows for the identification of microbiomes among and within the hosts. Incorporating the microbial host and biogeographic variation assists in the forest corridor assessments, which helps in gaining a proper understanding of microbial pathogens. Adoption of these methods would help in protecting endangered species.
Attributes |
Details |
Japan Market Expected Size (2033) |
US$ 24.9 million |
Japan Market Absolute Dollar Growth |
US$ 10 million |
CAGR % 2017 to 2022 |
5.8% |
India: Massive number of diabetic patients to drive growth
India is home to numerous diabetic patients in the world. Based on a survey conducted in December 2022, there are more than 74 million adults who suffer from diabetes. This is to say that 1 in 6 adults suffer from diabetes.
Attributes |
Details |
India Market Expected Size (2033) |
US$ 20.9 million |
India Market Absolute Dollar Growth |
US$ 10.1 million |
CAGR % 2017 to 2022 |
7.4% |
The metagenomic shotgun sequencing and metabolomic profiling identify specific human gut microbiota associated with diabetic retinopathy in type 2 diabetes. Healthcare has recently suggested a functional model for the development of autoimmunity for type 1 diabetes. These developments are expected to surge the demand for metagenomics in India.
Segmentation Insights
Segment | Product Type |
Attributes | Library Preparation Kits |
CAGR % 2017 to 2022 | 6.3% |
CAGR % 2023 to 2033 | 7.2% |
Segment | Application |
Attributes | Clinical Diagnostics |
CAGR % 2017 to 2022 | 6.8% |
CAGR % 2023 to 2033 | 8.3% |
Why is the demand for library preparation kits rising?
Sales of library preparation kits to rise at robust pa ace as gene sequencing gains centerstage
As per FMI, sales in the library preparation kits segment accounted for a share of 42.0% in 2022.
DNA and RNA sequencing practices are gaining traction owing to their ability to provide valuable data about gene sequences in a small duration of time. The data generated through gene sequencing is then analyzed and used by clinicians, scientists, and researchers across various verticals such as agriculture, forensics, etc.
Library preparation kits provide efficient and quick extraction of gene segments which are then used for analysis. Moreover, advancements in technology are encouraging manufacturers to launch novel products that reduce error and stress while improving accuracy.
Which is the leading application of metagenomics?
Clinical diagnostics to remain a key application area for metagenomics
By application, demand in the clinical diagnostics and bioremediation segments is expected to remain high over the forecast period. During the last few decades, metagenomics has gained immense traction across the healthcare industry where it is being utilized for diagnostic procedures.
Similarly, metagenomics procedures are being adopted for reducing toxicity in the environment. The rising usage of metagenomics in clinical diagnostics and bioremediation is anticipated to boost the growth in the market during the forecast period.
Which is the dominant end-use industry in the market?
Demand for metagenomics remains high in pharmaceutical industries and academic and research Institutes
In terms of end use, pharmaceutical, and academic & research segments are likely to generate the maximum revenue through 2033.
With the rising prevalence of multiple chronic diseases, pharmaceutical companies and government health organizations are investing in the development of innovative drugs. Thus, the application of metagenomics is expected to increase over the forecast period. Similarly, various research activities are being conducted across educational institutions for studying and elucidating the genetic structure of microbial communities.
Start-ups develop Automation enabled Metagenomics Solution
The start-ups have developed metagenomic screening tools to aid bio-discovery. The platform developed by them enables the expression of genes from diverse sources. The combination of automation, computation, and high-throughput screening assists in capturing a large variety of proteins.
Metagenomi: The start-up utilizes metagenomics to discover next-generation gene-editing tools. The discovery engine developed by Metagenomi uses AI-backed cloud computing to find natural enzyme systems in microbial environments. It finds compact nucleases that enable the delivery of AAV vectors. The search solution developed by them is mainly for therapeutic solutions. In January 2023, Metagenomi closed oversubscribed Series B funding standing at US$ 275 million to lead therapeutic programs into clinical development.
Key Manufacturers sign Strategic Collaborations to Enhance Research Prowess
The key players look to form profitable strategic collaborations. This would enable them to develop a combined framework of technologies that can increase the yield and find promising drugs based on human omics insights. In October 2022, Illumina launched a strategic collaboration with AstraZeneca for accelerating drug target discovery.
Key developments in the market are:
- In November 2022, Illumina boosted its genomic innovation in the United Arab Emirates through a new state-of-the-art solutions center.
- In November 2022, PerkinElmer helped accelerate gene therapy research with industry-first ready-to-use viral vector assays.
Dominant players in the market are:
Company |
Description |
Illumina |
Illumina has always worked towards improving human health by unlocking the power of the genome. By delivering breakthroughs in genomics, the company empowers visionaries around the globe to uncover answers. The company has enabled researchers and clinicians to turn big dreams into impactful genomic discoveries that improve lives. Inspired by deep customer insights, Illumina leads the way in delivering purposeful advances that address critical needs and enable support researchers. |
PerkinElmer |
PerkinElmer is a global provider of end-to-end solutions which help scientists, researchers, and clinicians better diagnose disease. With more than an 8-decade legacy of advancing science, the team of more than 16,000 collaborates with healthcare, academic, commercial, and government customers. The company reported revenues of more than US$ 5 billion in 2021 and is currently serving in more than 190 countries. It is a component of the prestigious S&P 500 index. |
Trivitron Healthcare Pvt. Ltd. |
Being a part of this niche for more than two and a half decades, the journey of Trivitron as a medical technology presents a fascinating thread of inspiration. The company has been marketing its products to hospitals, healthcare providers, independent clinics, and laboratories. As a pioneer in this field, the company constantly pursues technological innovation to offer superior benefits at a lower cost. The company believes in delivering quality healthcare as a fundamental right. |
Other prominent companies profiled: are Qiagen N.V., and Thermo Fisher Scientific.
Metagenomics Market Segmentation
By Product Type:
- Library Preparation Kits
- Sample Extraction Kits
- Metagenomic Sequencing Kits
By Application:
- Microbial Diversity
- Bioremediation and Degradation
- Bio Surfactants and Antibiotics Production
- Clinical Diagnostics
- Others
By End User:
- Pharmaceutical Industries
- Research Laboratories
- Biotechnology Companies
- Pathology Laboratories
- Academic and Research Institutes
By Region:
- North America
- Latin America
- Europe
- Commonwealth of Independent States and Russia
- Japan
- Asia Pacific Excluding Japan
- The Middle East and Africa
Frequently Asked Questions
What is the expected Metagenomics Market size in 2023?
The metagenomics market is expected to hold US$ 202.9 million in 2023.
At what rate would Metagenomics Market Grow?
The metagenomics market is expected to advance at 6.9% CAGR from 2023 to 2033.
What is the Demand Forecast for the Metagenomics Market?
The metagenomics market is forecasted to surpass US$ 394.2 million by 2033.
Which Region is expected to be Highly Significant Metagenomics Market?
North America is projected to be the dominant market for metagenomics.
What are the Main Drivers of the Metagenomics Market?
The main drivers are: surging cases of chronic illnesses and increasing investments by the government authorities.
Table of Content
1. Executive Summary | Metagenomics Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ million) Analysis, 2017 to 2022 4.2. Current and Future Market Size Value (US$ million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ million) Analysis By Product Type, 2017 to 2022 5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Product Type, 2023 to 2033 5.3.1. Library Preparation Kits 5.3.2. Sample Extraction Kits 5.3.3. Sequencing Kits 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2022 5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ million) Analysis By Application, 2017 to 2022 6.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Application, 2023 to 2033 6.3.1. Microbial Diversity 6.3.2. Bioremediation and Degradation 6.3.3. Bio Surfactants and Antibiotics Production 6.3.4. Clinical Diagnostics 6.3.5. Others 6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2022 6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ million) Analysis By End User, 2017 to 2022 7.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By End User, 2023 to 2033 7.3.1. Pharmaceutical Industries 7.3.2. Research Laboratories 7.3.3. Biotechnology Companies 7.3.4. Pathology Laboratories 7.3.5. Academic and Research Institutes 7.3.6. Others 7.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022 7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ million) Analysis By Region, 2017 to 2022 8.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. CIS & Russia 8.3.5. Asia-Pacific excluding Japan (APEJ) 8.3.6. Japan 8.3.7. Middle East and Africa (MEA) 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 9.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. United States of America 9.2.1.2. Canada 9.2.2. By Product Type 9.2.3. By Application 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Application 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product Type 10.2.3. By Application 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Application 10.3.4. By End User 10.4. Key Takeaways 11. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. EU-4 11.2.1.2. United Kingdom 11.2.1.3. BENELUX 11.2.1.4. Rest of Europe 11.2.2. By Product Type 11.2.3. By Application 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Application 11.3.4. By End User 11.4. Key Takeaways 12. CIS & Russia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 12.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.2. By Product Type 12.2.3. By Application 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Application 12.3.4. By End User 12.4. Key Takeaways 13. APEJ Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 13.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. India 13.2.1.3. ASEAN 13.2.1.4. South Korea 13.2.1.5. Rest of APEJ 13.2.2. By Product Type 13.2.3. By Application 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Application 13.3.4. By End User 13.4. Key Takeaways 14. Japan Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 14.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.2. By Product Type 14.2.3. By Application 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Application 14.3.4. By End User 14.4. Key Takeaways 15. MEA Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022 15.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Rest of MEA 15.2.2. By Product Type 15.2.3. By Application 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Application 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. United States of America 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Product Type 16.1.2.2. By Application 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Product Type 16.2.2.2. By Application 16.2.2.3. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Product Type 16.3.2.2. By Application 16.3.2.3. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Product Type 16.4.2.2. By Application 16.4.2.3. By End User 16.5. EU-4 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Product Type 16.5.2.2. By Application 16.5.2.3. By End User 16.6. United Kingdom 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Product Type 16.6.2.2. By Application 16.6.2.3. By End User 16.7. BENELUX 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Product Type 16.7.2.2. By Application 16.7.2.3. By End User 16.8. CIS & Russia 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Product Type 16.8.2.2. By Application 16.8.2.3. By End User 16.9. China 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Product Type 16.9.2.2. By Application 16.9.2.3. By End User 16.10. India 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Product Type 16.10.2.2. By Application 16.10.2.3. By End User 16.11. ASIAN 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Product Type 16.11.2.2. By Application 16.11.2.3. By End User 16.12. South Korea 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Product Type 16.12.2.2. By Application 16.12.2.3. By End User 16.13. Japan 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Product Type 16.13.2.2. By Application 16.13.2.3. By End User 16.14. GCC Countries 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Product Type 16.14.2.2. By Application 16.14.2.3. By End User 16.15. South Africa 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Product Type 16.15.2.2. By Application 16.15.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product Type 17.3.3. By Application 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Illumina Inc 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Perkin Elmer Inc. 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Trivitron Healthcare Pvt. Ltd. 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Qiagen N.V. 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Thermo Fisher Scientific 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Symbio Scientific Pvt. Ltd. 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Infobio 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Bio-Rad Laboratories 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Merck KgaA 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Promega Corporation 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value (US$ million) Forecast by Region, 2017 to 2033 Table 2: Global Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 3: Global Market Value (US$ million) Forecast by Application, 2017 to 2033 Table 4: Global Market Value (US$ million) Forecast by End User, 2017 to 2033 Table 5: North America Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 6: North America Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 7: North America Market Value (US$ million) Forecast by Application, 2017 to 2033 Table 8: North America Market Value (US$ million) Forecast by End User, 2017 to 2033 Table 9: Latin America Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 10: Latin America Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 11: Latin America Market Value (US$ million) Forecast by Application, 2017 to 2033 Table 12: Latin America Market Value (US$ million) Forecast by End User, 2017 to 2033 Table 13: Europe Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 14: Europe Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 15: Europe Market Value (US$ million) Forecast by Application, 2017 to 2033 Table 16: Europe Market Value (US$ million) Forecast by End User, 2017 to 2033 Table 17: CIS & Russia Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 18: CIS & Russia Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 19: CIS & Russia Market Value (US$ million) Forecast by Application, 2017 to 2033 Table 20: CIS & Russia Market Value (US$ million) Forecast by End User, 2017 to 2033 Table 21: APEJ Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 22: APEJ Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 23: APEJ Market Value (US$ million) Forecast by Application, 2017 to 2033 Table 24: APEJ Market Value (US$ million) Forecast by End User, 2017 to 2033 Table 25: Japan Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 26: Japan Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 27: Japan Market Value (US$ million) Forecast by Application, 2017 to 2033 Table 28: Japan Market Value (US$ million) Forecast by End User, 2017 to 2033 Table 29: MEA Market Value (US$ million) Forecast by Country, 2017 to 2033 Table 30: MEA Market Value (US$ million) Forecast by Product Type, 2017 to 2033 Table 31: MEA Market Value (US$ million) Forecast by Application, 2017 to 2033 Table 32: MEA Market Value (US$ million) Forecast by End User, 2017 to 2033
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ million) by Product Type, 2023 to 2033 Figure 2: Global Market Value (US$ million) by Application, 2023 to 2033 Figure 3: Global Market Value (US$ million) by End User, 2023 to 2033 Figure 4: Global Market Value (US$ million) by Region, 2023 to 2033 Figure 5: Global Market Value (US$ million) Analysis by Region, 2017 to 2033 Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 8: Global Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 9: Global Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 10: Global Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 11: Global Market Value (US$ million) Analysis by Application, 2017 to 2033 Figure 12: Global Market Value Share (%) and BPS Analysis by Application, 2023 to 2033 Figure 13: Global Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033 Figure 14: Global Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 15: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 16: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 17: Global Market Attractiveness by Product Type, 2023 to 2033 Figure 18: Global Market Attractiveness by Application, 2023 to 2033 Figure 19: Global Market Attractiveness by End User, 2023 to 2033 Figure 20: Global Market Attractiveness by Region, 2023 to 2033 Figure 21: North America Market Value (US$ million) by Product Type, 2023 to 2033 Figure 22: North America Market Value (US$ million) by Application, 2023 to 2033 Figure 23: North America Market Value (US$ million) by End User, 2023 to 2033 Figure 24: North America Market Value (US$ million) by Country, 2023 to 2033 Figure 25: North America Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 28: North America Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 29: North America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 30: North America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 31: North America Market Value (US$ million) Analysis by Application, 2017 to 2033 Figure 32: North America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033 Figure 33: North America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033 Figure 34: North America Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 35: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 36: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 37: North America Market Attractiveness by Product Type, 2023 to 2033 Figure 38: North America Market Attractiveness by Application, 2023 to 2033 Figure 39: North America Market Attractiveness by End User, 2023 to 2033 Figure 40: North America Market Attractiveness by Country, 2023 to 2033 Figure 41: Latin America Market Value (US$ million) by Product Type, 2023 to 2033 Figure 42: Latin America Market Value (US$ million) by Application, 2023 to 2033 Figure 43: Latin America Market Value (US$ million) by End User, 2023 to 2033 Figure 44: Latin America Market Value (US$ million) by Country, 2023 to 2033 Figure 45: Latin America Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 48: Latin America Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 51: Latin America Market Value (US$ million) Analysis by Application, 2017 to 2033 Figure 52: Latin America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033 Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033 Figure 54: Latin America Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 57: Latin America Market Attractiveness by Product Type, 2023 to 2033 Figure 58: Latin America Market Attractiveness by Application, 2023 to 2033 Figure 59: Latin America Market Attractiveness by End User, 2023 to 2033 Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 61: Europe Market Value (US$ million) by Product Type, 2023 to 2033 Figure 62: Europe Market Value (US$ million) by Application, 2023 to 2033 Figure 63: Europe Market Value (US$ million) by End User, 2023 to 2033 Figure 64: Europe Market Value (US$ million) by Country, 2023 to 2033 Figure 65: Europe Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 68: Europe Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 69: Europe Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 70: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 71: Europe Market Value (US$ million) Analysis by Application, 2017 to 2033 Figure 72: Europe Market Value Share (%) and BPS Analysis by Application, 2023 to 2033 Figure 73: Europe Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033 Figure 74: Europe Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 75: Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 76: Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 77: Europe Market Attractiveness by Product Type, 2023 to 2033 Figure 78: Europe Market Attractiveness by Application, 2023 to 2033 Figure 79: Europe Market Attractiveness by End User, 2023 to 2033 Figure 80: Europe Market Attractiveness by Country, 2023 to 2033 Figure 81: CIS & Russia Market Value (US$ million) by Product Type, 2023 to 2033 Figure 82: CIS & Russia Market Value (US$ million) by Application, 2023 to 2033 Figure 83: CIS & Russia Market Value (US$ million) by End User, 2023 to 2033 Figure 84: CIS & Russia Market Value (US$ million) by Country, 2023 to 2033 Figure 85: CIS & Russia Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 86: CIS & Russia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 87: CIS & Russia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 88: CIS & Russia Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 89: CIS & Russia Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 90: CIS & Russia Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 91: CIS & Russia Market Value (US$ million) Analysis by Application, 2017 to 2033 Figure 92: CIS & Russia Market Value Share (%) and BPS Analysis by Application, 2023 to 2033 Figure 93: CIS & Russia Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033 Figure 94: CIS & Russia Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 95: CIS & Russia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 96: CIS & Russia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 97: CIS & Russia Market Attractiveness by Product Type, 2023 to 2033 Figure 98: CIS & Russia Market Attractiveness by Application, 2023 to 2033 Figure 99: CIS & Russia Market Attractiveness by End User, 2023 to 2033 Figure 100: CIS & Russia Market Attractiveness by Country, 2023 to 2033 Figure 101: APEJ Market Value (US$ million) by Product Type, 2023 to 2033 Figure 102: APEJ Market Value (US$ million) by Application, 2023 to 2033 Figure 103: APEJ Market Value (US$ million) by End User, 2023 to 2033 Figure 104: APEJ Market Value (US$ million) by Country, 2023 to 2033 Figure 105: APEJ Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 106: APEJ Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 107: APEJ Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 108: APEJ Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 109: APEJ Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 110: APEJ Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 111: APEJ Market Value (US$ million) Analysis by Application, 2017 to 2033 Figure 112: APEJ Market Value Share (%) and BPS Analysis by Application, 2023 to 2033 Figure 113: APEJ Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033 Figure 114: APEJ Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 115: APEJ Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 116: APEJ Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 117: APEJ Market Attractiveness by Product Type, 2023 to 2033 Figure 118: APEJ Market Attractiveness by Application, 2023 to 2033 Figure 119: APEJ Market Attractiveness by End User, 2023 to 2033 Figure 120: APEJ Market Attractiveness by Country, 2023 to 2033 Figure 121: Japan Market Value (US$ million) by Product Type, 2023 to 2033 Figure 122: Japan Market Value (US$ million) by Application, 2023 to 2033 Figure 123: Japan Market Value (US$ million) by End User, 2023 to 2033 Figure 124: Japan Market Value (US$ million) by Country, 2023 to 2033 Figure 125: Japan Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 126: Japan Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 127: Japan Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 128: Japan Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 129: Japan Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 130: Japan Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 131: Japan Market Value (US$ million) Analysis by Application, 2017 to 2033 Figure 132: Japan Market Value Share (%) and BPS Analysis by Application, 2023 to 2033 Figure 133: Japan Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033 Figure 134: Japan Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 135: Japan Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 136: Japan Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 137: Japan Market Attractiveness by Product Type, 2023 to 2033 Figure 138: Japan Market Attractiveness by Application, 2023 to 2033 Figure 139: Japan Market Attractiveness by End User, 2023 to 2033 Figure 140: Japan Market Attractiveness by Country, 2023 to 2033 Figure 141: MEA Market Value (US$ million) by Product Type, 2023 to 2033 Figure 142: MEA Market Value (US$ million) by Application, 2023 to 2033 Figure 143: MEA Market Value (US$ million) by End User, 2023 to 2033 Figure 144: MEA Market Value (US$ million) by Country, 2023 to 2033 Figure 145: MEA Market Value (US$ million) Analysis by Country, 2017 to 2033 Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 148: MEA Market Value (US$ million) Analysis by Product Type, 2017 to 2033 Figure 149: MEA Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 150: MEA Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 151: MEA Market Value (US$ million) Analysis by Application, 2017 to 2033 Figure 152: MEA Market Value Share (%) and BPS Analysis by Application, 2023 to 2033 Figure 153: MEA Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033 Figure 154: MEA Market Value (US$ million) Analysis by End User, 2017 to 2033 Figure 155: MEA Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 156: MEA Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 157: MEA Market Attractiveness by Product Type, 2023 to 2033 Figure 158: MEA Market Attractiveness by Application, 2023 to 2033 Figure 159: MEA Market Attractiveness by End User, 2023 to 2033 Figure 160: MEA Market Attractiveness by Country, 2023 to 2033
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports